Current Issue


VOL 13 NO 8 • Nov/Dec 2022


This issue’s cover illustration depicts a hand with a blood draw against the background of a blood vessel. The artery shows fragments of DNA from tumors (indicated in upper left of image). The color coding indicates that DNA fragments are located in the plasma of the separated blood draw. Artwork by Alexandra Webber Baker © 2022, DNA Illustrations, Inc., Asheville, North Carolina.


Editorial

JADPRO Live 2022: Reaching the Peak of Practice

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

The 2022 JADPRO Live conference was held in person from October 20 to 23 in Aurora, Colorado. I was excited to finally see peers I had only met virtually throughout these past 2 years. Numerous advanced practitioner–designed sessions on solid tumors and hematologic malignancies were held. Notable...


Editorial

Inclusion of Racial and Ethnic Minorities in Cancer Clinical Trials: 30 Years After the NIH Revitalization Act, Where Are We?

Faith Mutale, DNP, CRNP

Improving diversity in cancer clinical trials is critically important to improve patient outcomes. The lack of diversity in clinical trials continues to be a concern among policymakers, including stakeholders such as trial investigators, advocacy groups, and consensus groups like the Oncology Nur...


Research and Scholarship

Advanced Practitioner-Led Shared Visits: A Novel Approach to Cancer Survivorship

Dana McDaniel, DNP, APRN, FNP-C, AOCNP®

Approximately 268,600 cases of invasive breast cancer were diagnosed in the United States in 2019 (National Institutes of Health, 2019). Improvement in prevention, detection, and efficacious treatment translates to more women surviving breast cancer. In the US, there has been a significant increa...


Research and Scholarship

Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study

Dan Beverly Fu,(1) DNP, MBA, NP-C, Xiao-Tang Kong,(1) MD, PhD, Tener Goodwin Veenema,(2) PhD, MPH, MS, Daniela A. Bota,(1) MD, PhD, and Binu Koirala,(3) PhD, MGS, RN

Seizures are common initial symptoms among patients with a brain neoplasm (Chandra et al., 2017). It is common practice to administer prophylactic antiepileptic drugs (AEDs) to patients undergoing brain tumor resection to prevent seizure activity during surgery (Chandra et al., 2017; Kong et al.,...


Review Article

Liquid Biopsy for Guiding Treatment Decisions in Advanced Non–Small Cell Lung Cancer

Gretchen Suk, DMSc, PA-C

The National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) data estimate 130,180 lung cancer deaths in the United States in 2022. The American Cancer Society estimates approximately 236,740 new lung cancer cases in 2022. Approximately 85% of these cases will be non–small cel...


Review Article

Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor Type

Neda Alrawashdh,(1,2) PhD, PharmD, Ali McBride,(3) PharmD, MS, BCPS, Mok Oh,(1) PhD, PharmD, Nimer Alkhatib,(1) PhD, PharmD, Christopher Lee,(4) PhD, RN, FAHA, FAAN, FHFSA, Jennifer Martin,(5) MA, Karen MacDonald,(6) PhD, RN, and Ivo Abraham,(1,3,6) PhD, RN

Severe chemotherapy-induced neutropenia (CIN) is a major dose-limiting toxicity associated with myelosuppressive regimens. Chemotherapy-induced neutropenia is classified as grade 4 when the absolute neutrophil count (ANC) is < 500/µl and grade 3 for ANCs < 1,000/µl but > 500/µl. Febrile ...


Grand Rounds

A Rare Event of Liver Dysfunction on Sotorasib and Management Strategy

Holly Kinahan, MSN, ANP-C, AOCNP®

Case Study A 76-year-old man from Florida was diagnosed in 2018 with moderately differentiated adenocarcinoma consistent with a lung primary after his hairdresser noted a lesion on the left parieto-occipital skull. This prompted him to seek medical attention, initially undergoing CT of the brain ...


Practice Matters

Supporting Advanced Practice Fellowship During COVID-19

Miranda Osborne,(1) MSN, RN-BC, CEN®, Amy Rettig,(2) DNP, MALM, APRN-BC, Amy Lindsey,(2) MS, APRN-CNS, PMHCNS-BC, Kris Mathey,(2) MS, APRN-CNP, AOCNP®, Loraine Sinnott,(3) PhD, and Diana McMahon,(2) DNP, MSN, RN, OCN®

Preparing new graduates for nurse practitioner (NP) or physician assistant (PA) roles in oncology requires formal orientation and education for a successful transition (Alencar et al., 2018). Most graduate programs in the country prepare NPs and PAs, part of the advanced practice provider (APP) w...


Diagnostic Snapshot

What Is Happening to This Patient With a Rare Leukemia?

Amandine Ndje, MS, MBA, APRN, FNP-C, and Jacqueline B. Broadway-Duren, PhD, DNP, APRN, FNP-BC

History Mr. Jones is a 68-year-old male with a rare leukemia called blastic plasmacytoid dendritic cell neoplasm (BPDCN) who was recently treated with a CD123-directed cytotoxin, tagraxofusp (Elzonris; SL-401). He presents to the emergency center with fever (38.4°C), headaches, a transient nosebl...


Editorial

Thank You to Our Peer Reviewers!


In this last issue of the year, we would like to acknowledge the 85 reviewers who completed peer reviews for JADPRO in the past year. Our reviewers practice in a range of oncology specialties and professions and dedicate their time and expertise to provide thoughtful, constructive feedback. Their...


Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.